Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hyperkalemia
Manufacturing
AZ to spend $445M to boost production of Lokelma at Texas plant
AstraZeneca will spend $445 million to upgrade it plant in Coppell, Texas, which is the company's lone site that produces hyperkalemia drug Lokelma.
Kevin Dunleavy
Oct 15, 2025 11:43am
Glenmark recalls 114 lots of low potassium drug in the US
Jun 25, 2024 10:40am
AZ puts kibosh on two studies of hyperkalemia med Lokelma
Dec 1, 2023 9:45am
AstraZeneca backs new hyperkalemia public awareness video series
Mar 6, 2023 9:24am
Labeling error prompts recall of Alembic hypertension med
Mar 25, 2021 8:16am
AZ finally wins hard-fought FDA nod for ZS-9, now dubbed Lokelma
May 21, 2018 11:10am